The ninth author's name is spelled incorrectly. The correct name is: Nobukata Kazawa.

In Table 3 the description of the dose of pirfenidone is incorrect. The correct dose of pirfenidone is: 600 mg (n)/1200mg(n)/1800mg(n). Please see the corrected [Table 3](#pone.0160231.t001){ref-type="table"} here.
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###### Clinical and physiologic data of the study population.

![](pone.0160231.t001){#pone.0160231.t001g}

  Parameters                                              IPF patients     Control
  ------------------------------------------------------- ---------------- -------------
  Total (n)                                               27               13
  Gender, male/female (n)                                 17 / 10          3 / 10
  Age (years)                                             75.5 ± 6.9       59.5 ± 11.8
  Never smoker (n)                                        10               8
  Past smoker (n)                                         17               5
  (pack-year)                                             51 ± 34          23 ± 14.4
  Body mass index (kg/m^2^)                               22.4 ± 3.7       23.9 ± 3.1
  Japanese stage I (n) / II (n) / III (n) / IV (n)        11 / 4 / 9 / 3   NA
  GAP stage I (n) / II (n) / III (n)                      12 / 6 / 9       NA
  Serum KL-6 (U/mL)                                       1256 ± 1057      NA
  Treatment with prednisolone (n)                         8                NA
  Dose of prednisolone (mg)                               11.5 ± 4.9\*     NA
  Treatment with pirfenidone (n)                          12               NA
  Dose of pirfenidone, 600 mg (n)/1200mg (n)/1800mg (n)   5 / 4 / 3        NA
  Home oxygen treatment (n)                               7                NA
  sPAP assessed with echocardiography \>45 Torr (n)       3                NA
  FVC (mL)                                                2303 ± 770       3080 ± 835
  %FVC (%)                                                79.2 ± 18.3      112 ± 20.6
  FEV~1~/FVC (%)                                          84.1 ± 9.9       76.3 ± 8.5
  DLco (mL/min/mmHg)                                      9.1 ± 3.8        NA
  %DLco (%)                                               42.8 ± 16.4      NA
  TLC (mL)                                                3568 ± 1001      NA
